Screener

Net Income (Loss) Available to Common Stockholders, Basic

Name: BridgeBio Pharma Net Income (Loss) Available to Common Stockholders, Basic by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BridgeBio Pharma·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$182.74M	-$192.86M	-$164.04M
Total	-$184.94M	-$194.64M	-$166.56M

Segments

Business SegmentsView metric